Search

Your search keyword '"Marboe C"' showing total 304 results

Search Constraints

Start Over You searched for: Author "Marboe C" Remove constraint Author: "Marboe C"
304 results on '"Marboe C"'

Search Results

1. Plasma Cell-Free DNA Chromatin Immunoprecipitation Distinguishes Acute Rejection Subtypes After Heart Transplantation

2. Cell-Free DNA to Unveil Potential Mechanisms of Racial Disparities in Lung Transplant

3. (220) Cell-Free DNA Enhances Pathologist Interrater Reliability at the Assessment of Acute Rejection on Endomyocardial Biopsy, on Behalf of the GRAfT Investigators

4. (130) Dysregulated Circulating Proteins in Cellular and Antibody-Mediated Rejection, on Behalf of the Graft Investigators

5. Comparative Performance Analysis of Donor-Derived Cell-Free DNA to Detect Acute Rejection in Single and Double Lung Transplant Recipients

6. Cell-Free DNA to Distinguish High Risk Donor Specific Antibodies in Heart Transplantation

8. Circulating microRNA Biomarkers in Cellular and Antibody-Mediated Heart Transplant Rejection

12. Impact of AMR Treatment: Responders vs Non-Responders Characteristics

13. Racial Differences in Immunosuppression and Lung Transplant Outcomes

15. Cell-Free DNA to Monitor Immunosuppression Adequacy in Lung Transplantation

16. Increased Cell Free DNA Levels in African American Patients Early after Heart Transplantation

19. Allograft Injury and Outcomes in African American Lung Transplant Recipients

20. Association between Pretransplant Antibody against Angiotensin II Type 1 Receptor and Posttransplant Allograft Injury

21. Donor-Derived-Cell-Free DNA to Identify Primary Graft Dysfunction Patients at Risk of Chronic Lung Allograft Dysfunction

22. Outcomes of ISHLT Lung Transplant AMR

23. Early Donor-Derived Cell-Free DNA Predicts Peak Allograft Function in Heart Transplant

24. Lung Transplantation: DSA to AMR Trajectory

25. Early and Late Pulmonary AMR Show Distinct Profiles; Clinical and Epigenetic Analyses

26. To Treat or Not to Treat: DSA Positive Lung Transplant Recipients

27. Increased Cell Free DNA Levels in African American Patients Early after Heart Transplantation

31. Inflammatory Events Precede Development of De Novo DSA after Lung Transplantation

32. Antibody-mediated Rejection: Should We Wait for Clinical Diagnosis?

33. Giant Cell Myocarditis Patients Undergoing Heart Transplantation Have High Rates of Rejection, Infection and Cardiac Allograft Vasculopathy: Case Series

36. Prevalence of Polyreactive Innate-Like B Cells Among Graft-Infiltrating B Cells in Human Cardiac Allograft Vasculopathy

39. In vivo comparison between cardiac allograft vasculopathy and native atherosclerosis using near-infrared spectroscopy and intravascular ultrasound

40. NEW ONSET GRAFT DYSFUNCTION AFTER HEART TRANSPLANTATION - INCIDENCE AND MECHANISM-RELATED IN-HOSPITAL OUTCOMES

41. IMMUNOLOGICAL TARGETS OF HIV-INFECTION - T-CELLS

42. 196: Variability in the Pathologic Interpretation of Trans-Bronchial Lung Biopsy after Lung Transplantation. Clinical Implications

43. Anti-CD25 treatment and FOXP3-positive regulatory T cells in heart transplantation

44. Application de la technique de tissue microarray (TMA) à 46 cas de carcinomes invasifs du sein colligés à l’INO avec étude immunohistochimique des récepteurs hormonaux, de Her2/neu, de l’E-cadhérine, de la béta-caténine, de PTEN et de p53

47. Non-invasive molecular screening for acute cardiac rejection: a multicenter prospective clinical study

Catalog

Books, media, physical & digital resources